Photo taken from American Society of Clinical Oncology (ASCO)/LinkedIn
Feb 6, 2024, 16:42
Triplet Therapy Offers New Treatment Option for Patients with Relapsed or Refractory Multiple Myeloma – ASCO
American Society of Clinical Oncology (ASCO) shared a post on their LinkedIn page:
“Latest from ASCO Plenary Series: Triplet Therapy Offers New Treatment Option for Patients with Relapsed or Refractory Multiple Myeloma. Tune in tomorrow, February 6, at 3 PM ET for the live presentation, expert discussion, and Q&A.
View abstract.”
Source: American Society of Clinical Oncology (ASCO)/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14